PAT-1251 T12371L
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
PAT-1251 is a potent, selective, and oral lysyl oxidase-like 2 inhibitor, with IC50s of 0.71 and 1.17 _M for hLOXL2 and hLOXL3, respectively. PAT-1251 is used in the research of fibrotic diseases. It also potently inhibits mouse, rat, and dog LOXL2 (IC50s
CAS nr:
2007885-39-2
Purity:
98%
Molecular Weight:
399,34
SMILES:
FC(F)(F)C1=NC(OC2=CC(C(N3C[C@@H](F)[C@H](O)C3)=O)=CC=C2)=CC(CN)=C1
Formula:
C18H17F4N3O3
Pathway:
Others
Target:
Others
